Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Douillard-Guilloux G, Guilloux JP, Lewis DA, Sibille E (2013)
Abstract Background and objective The efficacy and safety of L-carnitine supplementation on non-alcoholic fatty liver disease (NAFLD) are unclear
doi: 10.1016/j.bj.2023.100677 144
While GLP-1 agonists alone have a low intrinsic risk of causing low blood sugar, this risk increases significantly when they are used in combination with insulin or sulphonylureas, as noted in product SmPCs [11] [9] Possibly associated with rapid weight loss : Significant weight reduction might potentially lead to electrolyte imbalances or nutritional deficiencies that could contribute to tremor, though this mechanism is not well-established Coincidental : Tremors may develop independently of medication use, particularly in older adults or those with other underlying conditions If you develop new or worsening hand tremors whilst taking a GLP-1 agonist, it is essential to discuss this with your healthcare provider rather than assuming a direct causal relationship
US$ 28.84
US$ 26.97
US$ 29.73
US$ 29.97
